Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
VHTvsFTXHETF Comparison
Vanguard Health Care ETF (VHT) and First Trust Nasdaq Pharmaceuticals ETF (FTXH) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. VHT is less expensive with a Total Expense Ratio (TER) of 0.09%, versus 0.6% for FTXH. VHT is down -1.5% year-to-date (YTD) with -$151M in YTD flows. FTXH performs better with 5.06% YTD performance, and +$7M in YTD flows. Run a side-by-side ETF comparison of VHT and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
VHT vs FTXH performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | VHT FTXH | -1.42%-0.60% | +0.11%+7.47% | -1.50%+5.06% | +7.50%+22.29% | +30.03%+43.33% | +36.00%+43.47% |
| Flows | VHT FTXH | -$76M+$5M | -$238M+$9M | -$151M+$7M | -$712M+$10M | -$2.54B-$13M | -$233M+$4M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | VHT FTXH | +13.17%+15.29% | +17.33%+20.64% | +13.63%+15.87% | +14.97%+15.67% |
| Max drawdown | VHT FTXH | -5.00%-4.33% | -11.85%-17.49% | -16.88%-19.32% | -17.77%-19.32% |
| Max drawdown duration | VHT FTXH | 62d9d | 190d203d | 435d393d | 767d393d |
VHT | FTXH | |
Last sale 3/11/2026 at 1:30 PM | $282.75 | $34.46 |
| Previous close 03/10/2026 | $283.48 | $34.57 |
| Consolidated volume 03/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
VHT | FTXH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
VHT | FTXH | |
|---|---|---|
| Last price | $282.75 | $34.46 |
| 1D performance | -0.26% | -0.33% |
| AuM | $16.92 B | $29.41 M |
| E/R | 0.09% | 0.6% |
VHT | FTXH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Vanguard | First Trust |
| Benchmark | MSCI US IMI Health Care 25/50 Index | NASDAQ US Smart Pharmaceuticals Index |
| N° of holdings | 352 | 49 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | January 26, 2004 | September 20, 2016 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the VHT and FTXH ETFs performed in 2026?
As of March 10, 2026, VHT is down -1.5% year-to-date (YTD), while FTXH has returned 5.06%. That puts FTXH better performer ahead so far this year.
Which ETF is attracting more investor money: VHT or FTXH?
Year-to-date, the VHT ETF saw -$151M in flows, compared to +$7M for FTXH.
Which ETF is more volatile: VHT or FTXH?
Over the past year, VHT had a volatility of 17.33%, while FTXH experienced 20.64%.
Which ETF is bigger: VHT or FTXH?
As of March 10, 2026, VHT holds $16.92 B in assets under management (AUM), while FTXH manages $29.41 M.
What sectors do the VHT and FTXH ETFs invest in?
VHT leans toward sectors like Health Care. Meanwhile, FTXH focuses on Health Care.
What are the top holdings of the VHT ETF and FTXH ETF?
VHT top holdings include LILLY, JOHNSON&JOHNSON and ABBVIE. FTXH holds in its top three: MERCK & CO INC, JOHNSON&JOHNSON and BRISTOL-MYERS SQUIBB.
Which ETF is more diversified: VHT or FTXH?
VHT holds 408 securities with 60.02% of its assets in the top 15. FTXH has 50 securities and a top 15 weight of 71.63%.
My Contrarian Equity ETF Picks For 2026
Healthcare Stocks Drop on Medicare Payment Rate Surprise
Health Care Sector Down After a Cyberattack on UnitedHealth
2024 Stock Market Predictions from Vanguard, BlackRock, & State Street: ETFs to Watch
Tony's ETF Buyer's Guide: Sector ETFs (Vanguard versus State Street SPDR)
Defensive investing: Utility and healthcare sector ETFs
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
